Valuation : SMS Pharmaceuticals Limited

Market Cap 39.1B 409M 352M 332M 302M 565M 570M 3.95B 1.52B 19.83B 1.54B 1.5B 62.98B P/E 2025
27.3x
P/E 2026 33.6x
Enterprise Value 42.29B 442M 380M 359M 327M 611M 617M 4.27B 1.64B 21.45B 1.66B 1.62B 68.12B EV / Sales 2025
2.75x
EV / Sales 2026 4.31x
Free-Float
23.43%
Yield 2025
0.19%
Yield 2026 0.11%
1 day+2.49%
1 week+11.90%
Current month+12.26%
1 month+10.41%
3 months+10.60%
6 months+8.80%
Current year+34.49%
1 week 373
Extreme 373
444
1 month 349.25
Extreme 349.25
444
Current year 293.15
Extreme 293.15
447.8
1 year 242.25
Extreme 242.25
447.8
3 years 111.85
Extreme 111.85
447.8
5 years 54.55
Extreme 54.55
447.8
10 years 24
Extreme 24
447.8
Manager TitleAgeSince
Chief Executive Officer 66 30/08/1990
Director of Finance/CFO - 13/09/2017
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 66 30/08/1990
Director/Board Member 38 05/06/2020
Director/Board Member 48 29/05/2018
Change 5-day change 1-year change 3-year change Capi.($)
+2.49%+11.90%+67.98%+227.41% 401M
-0.21%-3.66%+16.92%+64.62% 47.02B
-1.80%-5.95%+34.69%+111.80% 39.94B
-0.85%-3.15%+7.94%+77.95% 11.82B
+0.75%-2.80%-11.49%+10.34% 11.57B
+0.19%+0.38%+19.41%+137.73% 9.18B
-0.40%-5.12%+34.30%-16.30% 7.2B
-0.82%-1.83%+14.11%+210.87% 7.22B
-0.72%-2.50%+24.28%+32.80% 7.32B
-1.43%-1.34%-44.42%+21.01% 5.2B
Average -0.28%-1.47%+16.37%+87.82% 14.69B
Weighted average by Cap. -0.69%-3.21%+17.99%+79.36%

Financials

2025 2026
Net sales 7.83B 81.87M 70.41M 66.43M 60.52M 113M 114M 791M 305M 3.97B 307M 301M 12.61B 8.89B 92.95M 79.93M 75.42M 68.71M 128M 130M 898M 346M 4.51B 349M 341M 14.32B
Net income 691M 7.23M 6.22M 5.87M 5.35M 9.99M 10.08M 69.88M 26.89M 351M 27.15M 26.56M 1.11B 1.02B 10.67M 9.17M 8.66M 7.89M 14.74M 14.87M 103M 39.68M 517M 40.06M 39.18M 1.64B
Net Debt 2.69B 28.16M 24.22M 22.85M 20.82M 38.92M 39.27M 272M 105M 1.37B 106M 103M 4.34B 3.19B 33.37M 28.7M 27.08M 24.67M 46.12M 46.54M 323M 124M 1.62B 125M 123M 5.14B
Logo SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of manufacturing active pharma ingredients and their intermediates. Its product categories include anti-ulcer, anti-inflammatory, anti-migraine, ant-diabetic, anti-coagulant, anti-viral, anti-retroviral, anti-psychotic, and others. The Company products include ranitidine, famotidine, pantoprazole sodium, itraconazole, lanoconazole, luliconazole, ibuprofen, Dex ibuprofen, fenoprofen calcium, sumatriptan, almotriptan, zolmitriptan, rizatriptan, Ele triptan, vildagliptin, sitagliptin, rosiglitazone, empagliflozin, dapagliflozin, tenofovir, dolutegravir, raltegravir, lamivudine, efavirenz, apixaban, rivaroxaban, levetiracetam, perampanel, lamotrigine, penciclovir, valaciclovir, and others. The Company has manufacturing facilities at Bachupally, Hyderabad, Telangana and also at Kandivalasa Village, Poosapatirega Mandal, Vijayanagaram District, Andhra Pradesh.
Employees
1,617
Date Price Change Volume
10/09/26 417.45 +2.49% 561,774
09/09/26 ₹407.30 +2.04% 523,724
08/09/26 ₹399.15 +0.30% 634,613
07/09/26 ₹397.95 +1.39% 3,870,958
04/09/26 ₹392.50 +4.90% 473,075

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SMSPHARMA Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!